174 related articles for article (PubMed ID: 19728081)
1. Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations.
Yu KD; Di GH; Li WF; Rao NY; Fan L; Yuan WT; Hu Z; Wu J; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 May; 121(1):157-67. PubMed ID: 19728081
[TBL] [Abstract][Full Text] [Related]
2. Analysis of GADD45A sequence variations in French Canadian families with high risk of breast cancer.
Desjardins S; Ouellette G; Labrie Y; Simard J; ; Durocher F
J Hum Genet; 2008; 53(6):490-498. PubMed ID: 18350249
[TBL] [Abstract][Full Text] [Related]
3. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
4. Germline RAP80 mutations and susceptibility to breast cancer.
Akbari MR; Ghadirian P; Robidoux A; Foumani M; Sun Y; Royer R; Zandvakili I; Lynch H; Narod SA
Breast Cancer Res Treat; 2009 Jan; 113(2):377-81. PubMed ID: 18306035
[TBL] [Abstract][Full Text] [Related]
5. Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis.
Huo X; Hu Z; Zhai X; Wang Y; Wang S; Wang X; Qin J; Chen W; Jin G; Liu J; Gao J; Wei Q; Wang X; Shen H
Breast Cancer Res Treat; 2007 May; 102(3):329-37. PubMed ID: 17028982
[TBL] [Abstract][Full Text] [Related]
6. RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer.
He M; Di GH; Cao AY; Hu Z; Jin W; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 May; 133(1):111-6. PubMed ID: 21811815
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphims of estrogen receptor alpha -397 PvuII (T>C) and -351 XbaI (A>G) in a portuguese population: prevalence and relation with breast cancer susceptibility.
Ramalhinho AC; Marques J; Fonseca-Moutinho JA; Breitenfeld L
Mol Biol Rep; 2013 Aug; 40(8):5093-103. PubMed ID: 23666105
[TBL] [Abstract][Full Text] [Related]
8. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
9. Association of common ATM variants with familial breast cancer in a South American population.
González-Hormazábal P; Bravo T; Blanco R; Valenzuela CY; Gómez F; Waugh E; Peralta O; Ortuzar W; Reyes JM; Jara L
BMC Cancer; 2008 Apr; 8():117. PubMed ID: 18433505
[TBL] [Abstract][Full Text] [Related]
10. Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent.
Cavallone L; Arcand SL; Maugard C; Ghadirian P; Mes-Masson AM; Provencher D; Tonin PN
BMC Cancer; 2008 Apr; 8():96. PubMed ID: 18402691
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.
Loizidou MA; Cariolou MA; Neuhausen SL; Newbold RF; Bashiardes E; Marcou Y; Michael T; Daniel M; Kakouri E; Papadopoulos P; Malas S; Hadjisavvas A; Kyriacou K
Breast Cancer Res Treat; 2010 May; 121(1):147-56. PubMed ID: 19714462
[TBL] [Abstract][Full Text] [Related]
12. Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing.
Li G; Guo X; Tang L; Chen M; Luo X; Peng L; Xu X; Wang S; Xiao Z; Yi W; Dai L; Wang J
J Cancer Res Clin Oncol; 2017 Oct; 143(10):2011-2024. PubMed ID: 28664449
[TBL] [Abstract][Full Text] [Related]
13. Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk.
Ricks-Santi LJ; Sucheston LE; Yang Y; Freudenheim JL; Isaacs CJ; Schwartz MD; Dumitrescu RG; Marian C; Nie J; Vito D; Edge SB; Shields PG
BMC Cancer; 2011 Jun; 11():278. PubMed ID: 21708019
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
Hsu HM; Wang HC; Chen ST; Hsu GC; Shen CY; Yu JC
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2024-32. PubMed ID: 17932350
[TBL] [Abstract][Full Text] [Related]
15. Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age.
Turkovic L; Gurrin LC; Bahlo M; Dite GS; Southey MC; Hopper JL
BMC Cancer; 2010 Sep; 10():466. PubMed ID: 20807450
[TBL] [Abstract][Full Text] [Related]
16. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
Blanco I; Kuchenbaecker K; Cuadras D; Wang X; Barrowdale D; de Garibay GR; Librado P; Sánchez-Gracia A; Rozas J; Bonifaci N; McGuffog L; Pankratz VS; Islam A; Mateo F; Berenguer A; Petit A; Català I; Brunet J; Feliubadaló L; Tornero E; Benítez J; Osorio A; Ramón y Cajal T; Nevanlinna H; Aittomäki K; Arun BK; Toland AE; Karlan BY; Walsh C; Lester J; Greene MH; Mai PL; Nussbaum RL; Andrulis IL; Domchek SM; Nathanson KL; Rebbeck TR; Barkardottir RB; Jakubowska A; Lubinski J; Durda K; Jaworska-Bieniek K; Claes K; Van Maerken T; Díez O; Hansen TV; Jønson L; Gerdes AM; Ejlertsen B; de la Hoya M; Caldés T; Dunning AM; Oliver C; Fineberg E; Cook M; Peock S; McCann E; Murray A; Jacobs C; Pichert G; Lalloo F; Chu C; Dorkins H; Paterson J; Ong KR; Teixeira MR; ; Hogervorst FB; van der Hout AH; Seynaeve C; van der Luijt RB; Ligtenberg MJ; Devilee P; Wijnen JT; Rookus MA; Meijers-Heijboer HE; Blok MJ; van den Ouweland AM; Aalfs CM; Rodriguez GC; Phillips KA; Piedmonte M; Nerenstone SR; Bae-Jump VL; O'Malley DM; Ratner ES; Schmutzler RK; Wappenschmidt B; Rhiem K; Engel C; Meindl A; Ditsch N; Arnold N; Plendl HJ; Niederacher D; Sutter C; Wang-Gohrke S; Steinemann D; Preisler-Adams S; Kast K; Varon-Mateeva R; Gehrig A; Bojesen A; Pedersen IS; Sunde L; Jensen UB; Thomassen M; Kruse TA; Foretova L; Peterlongo P; Bernard L; Peissel B; Scuvera G; Manoukian S; Radice P; Ottini L; Montagna M; Agata S; Maugard C; Simard J; Soucy P; Berger A; Fink-Retter A; Singer CF; Rappaport C; Geschwantler-Kaulich D; Tea MK; Pfeiler G; ; John EM; Miron A; Neuhausen SL; Terry MB; Chung WK; Daly MB; Goldgar DE; Janavicius R; Dorfling CM; van Rensburg EJ; Fostira F; Konstantopoulou I; Garber J; Godwin AK; Olah E; Narod SA; Rennert G; Paluch SS; Laitman Y; Friedman E; ; Liljegren A; Rantala J; Stenmark-Askmalm M; Loman N; Imyanitov EN; Hamann U; ; Spurdle AB; Healey S; Weitzel JN; Herzog J; Margileth D; Gorrini C; Esteller M; Gómez A; Sayols S; Vidal E; Heyn H; ; Stoppa-Lyonnet D; Léoné M; Barjhoux L; Fassy-Colcombet M; de Pauw A; Lasset C; Ferrer SF; Castera L; Berthet P; Cornelis F; Bignon YJ; Damiola F; Mazoyer S; Sinilnikova OM; Maxwell CA; Vijai J; Robson M; Kauff N; Corines MJ; Villano D; Cunningham J; Lee A; Lindor N; Lázaro C; Easton DF; Offit K; Chenevix-Trench G; Couch FJ; Antoniou AC; Pujana MA
PLoS One; 2015; 10(4):e0120020. PubMed ID: 25830658
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
18. BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity.
Juwle A; Saranath D
Med Oncol; 2012 Dec; 29(5):3272-81. PubMed ID: 22752604
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women Lu J; Wei Q; Bondy ML; Li D; Brewster A; Shete S; Yu TK; Sahin A; Meric-Bernstam F; Hunt KK; Singletary SE; Ross MI; Wang LE
Carcinogenesis; 2006 Nov; 27(11):2209-16. PubMed ID: 16714331
[TBL] [Abstract][Full Text] [Related]
20. Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
Mol Carcinog; 2010 Jun; 49(6):545-55. PubMed ID: 20306497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
